Aktiesnakken — Februar 2011
-
ja jeg er varm
-
skal vi i gruppe terapi
-
helt sikkert
-
ja. Kapitulation
-
Jeg regner med at vi får et nyt genmab at se i regnskabstallene
-
det må se ret meget anderledes going forward, med så mange færre folk og med GSK overtagelse af Arzerra
-
på mandag er vi klogere
-
ja RTH, det er humlen!
-
jeg kan ikke se hvad det skal være, alt er jo afskrevet og nedskrevet
-
men man kan jo altid blive negativt overrasket i Genmab
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind